Skip to content
Home/Companies/Pharma/Archimica
AR

Archimica

Pharma·Italy·Exited 2023·Held 4yr

Archimica is a pharma company, headquartered in Italy.

Entry
2019
Hold
4yr
Exit
2023
Est. EV
–

Who owns Archimica?

Archimica was owned by LIVIA Group through LIVIA Corporate Development (2013 vintage) from 2019 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

LIVIA Group
Investor
LIVIA Group
LIVIA Corporate Development · 2013 · Evergreen

Key facts

HQItaly
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from LIVIA Corporate Development

Other portfolio companies in the same fund.

Westpole
Active
SoftwareItaly· 2020
ALUCOM
Exited 2025
IndustrialsGermany· 2018
to
Baden Board and Packaging
Active
IndustrialsGermany· 2018
Tingari
Exited 2022
Business ServicesFrance· 2018
to
REFEL
Exited 2022
IndustrialsItaly· 2017
to
Coflace Food
Exited 2017
ConsumerNetherlands· 2016

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings